Mass General Brigham

Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research

Retrieved on: 
torsdag, maj 30, 2024

The award ceremony will take place on May 30, 2024 at the Consortium of Multiple Sclerosis Centers annual meeting being held in Nashville, Tennessee.

Key Points: 
  • The award ceremony will take place on May 30, 2024 at the Consortium of Multiple Sclerosis Centers annual meeting being held in Nashville, Tennessee.
  • “We are thrilled to see Dr. Howard Weiner recognized with the ‘Giants of MS’ award for his exceptional achievements in MS research,” said Gabriele Cerrone, Chairman, acting CEO, and founder of Tiziana Life Sciences.
  • Weiner's relentless pursuit of scientific excellence and commitment to improving patient outcomes also exemplifies the values we uphold at Tiziana.
  • This award acknowledges individuals who have demonstrated extraordinary leadership and innovation in the field of MS research.

Draganfly Announces First Quarter Results of 2024

Retrieved on: 
tisdag, maj 14, 2024

Vancouver, BC., May 14, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its first quarter financial results.

Key Points: 
  • Vancouver, BC., May 14, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its first quarter financial results.
  • Key Financial and Operational Highlights for Q1 2024:
    Revenue for the first quarter of 2024 was $1,329,581 which represents a 45% quarter over quarter increase and was down 17% year over year.
  • The Company recorded a comprehensive loss of $1,884,416 in the first quarter of 2024 compared to a comprehensive loss of $7,096,995 in the first quarter of 2023.
  • Draganfly will hold a shareholder update and earnings call on May 14, 2024 at 2:30 p.m. PDT / 5:30 p.m. EDT.

Heuron Gets FDA Green Light for Stroke Triage and Notification Solution

Retrieved on: 
torsdag, maj 23, 2024

Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea, announced that its non-contrast CT imaging analysis solution, Heuron ICH, has received FDA 510(k) clearance.

Key Points: 
  • Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea, announced that its non-contrast CT imaging analysis solution, Heuron ICH, has received FDA 510(k) clearance.
  • This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea for computer-aided triage and notification devices (CADt).
  • Heuron ICH becomes the fifth solution from Heuron to receive FDA clearance, following Veuron-Brain-mN1, Veuron-Brain-pAb, Heuron Beta Amyloid, and Veuron-Brain-pAb3.
  • Additionally, Heuron ICH successfully achieved the performance levels required by the FDA through clinical trials conducted last year in collaboration with Mass General Brigham, affiliated with Harvard Medical School.

Under The Patronage of the Ministry of Health 2024 Saudi-American Healthcare Forum Achieves Major Advances at XS Conferences & C3 Summit International Forum

Retrieved on: 
tisdag, maj 14, 2024

RIYADH, Saudi Arabia, May 14, 2024 /PRNewswire/ -- Leaders in Medicine, Government, Business and Technology attended the 10th Edition of the C3 International Saudi-American Healthcare Forum (SAHF) at the Ritz Carlton, Riyadh.

Key Points: 
  • Aligned with Saudi Arabia's Vision 2030 healthcare transformation its goal is to provide accessible, high-quality healthcare and to enhance the local workforce.
  • The 2024 Saudi-American Healthcare Forum brought together leading experts to identify the major healthcare challenges facing the US and Arab populations.
  • With a goal to identify ways to bring these major healthcare innovations to fruition in the region and the global market.
  • To learn more about the Saudi-American Healthcare Forum 2024, please visit https://sahf2024.com/ or contact: Dareen Kabbush at +1-917-742-9941 or [email protected] .

Labroots Announces the 12th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2024

Retrieved on: 
torsdag, maj 9, 2024

YORBA LINDA, Calif., May 9, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website and producer of educational virtual events and webinars, proudly announces the upcoming 12th Annual Precision Medicine Virtual Event Series. This premier virtual conference, scheduled for May 15, 2024, invites worldwide experts and enthusiasts to explore the latest innovations and advancements in precision medicine.

Key Points: 
  • Join Labroots on May 15, 2024, for the 12th Annual Precision Medicine Virtual Event Series, exploring the latest in genomics, genetics, and molecular diagnostics, with keynote speakers, dynamic sessions, and opportunities for continuing education.
  • YORBA LINDA, Calif., May 9, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website and producer of educational virtual events and webinars, proudly announces the upcoming 12th Annual Precision Medicine Virtual Event Series .
  • This premier virtual conference, scheduled for May 15, 2024, invites worldwide experts and enthusiasts to explore the latest innovations and advancements in precision medicine.
  • This year's event will dive deep into the cutting-edge areas of genomics, genetics, and molecular diagnostics, pivotal in the ongoing revolution of personalized healthcare.

BrainTale Accelerates Its International Expansion and Unveils Tier-one Collaborations to Improve Brain Care and Enable Precision Neurology

Retrieved on: 
måndag, maj 6, 2024

BrainTale, a medtech deciphering white matter to enable better brain care, spin-off of the Paris Region Greater Hospitals, unveils today a selection of leading research centers collaborations.

Key Points: 
  • BrainTale, a medtech deciphering white matter to enable better brain care, spin-off of the Paris Region Greater Hospitals, unveils today a selection of leading research centers collaborations.
  • Accordingly, since its creation in 2018, BrainTale has been developing non-invasive, accessible, actionable and clinically validated measurement and predictive tools for patients suffering from brain diseases.
  • With a strong collaborative approach, the company’s ambition is to provide investigators with relevant measure of the brain to improve patient care and clinical development of new disease-modifying drugs.
  • « Our collaborative approach is the foundation of BrainTale’ strategy to establish white matter measure as a reference to ultimately contribute to a better brain care.

SREE CHAGUTURU, MD, CHIEF MEDICAL OFFICER, CVS HEALTH, BECOMES CHAIR OF THE AMERICAN TELEMEDICINE ASSOCIATION BOARD OF DIRECTORS

Retrieved on: 
fredag, maj 3, 2024

WASHINGTON, May 3, 2024 /PRNewswire/ -- The American Telemedicine Association (ATA) today announced that Sree Chaguturu, MD, has become Chair of the Board of Directors.

Key Points: 
  • WASHINGTON, May 3, 2024 /PRNewswire/ -- The American Telemedicine Association (ATA) today announced that Sree Chaguturu, MD, has become Chair of the Board of Directors.
  • Dr. Chaguturu is Executive Vice President and Chief Medical Officer, CVS Health®, where he leads the enterprise medical affairs organization spanning across all segments: Aetna®, CVS HealthSpire®, CVS Pharmacy®.
  • Dr. Chaguturu becomes ATA Chair of the Board beginning immediately, succeeding Kristi Henderson, DNP, FAAN, CEO, Confluent Health.
  • Before joining CVS Health, Sree was chief population health officer of Mass General Brigham, the largest health care system in Massachusetts.

MASTERCARD FOUNDATION INTRODUCES MFAM, A NEW SEPARATE ASSET MANAGEMENT COMPANY, TO SUPPORT ITS PHILANTHROPIC MISSION

Retrieved on: 
torsdag, maj 2, 2024

TORONTO, May 2, 2024 /PRNewswire/ - The Mastercard Foundation today introduced the Mastercard Foundation Asset Management (MFAM) Corporation , a new, separate asset management company with a mandate to build and manage a diversified portfolio to support the mission of the Mastercard Foundation and the work of its partners over the long term.

Key Points: 
  • TORONTO, May 2, 2024 /PRNewswire/ - The Mastercard Foundation today introduced the Mastercard Foundation Asset Management (MFAM) Corporation , a new, separate asset management company with a mandate to build and manage a diversified portfolio to support the mission of the Mastercard Foundation and the work of its partners over the long term.
  • The Mastercard Foundation was established in 2006 through the generosity of Mastercard Incorporated (NYSE: MA), which gifted the Mastercard Foundation common shares as part of its initial public offering.
  • The Mastercard Foundation now requires a dedicated asset management team to manage and diversify the Mastercard Foundation's growing investment portfolio.
  • MFAM was established by the Mastercard Foundation as a separate entity with a separate Board of Directors and management team.

MASTERCARD FOUNDATION INTRODUCES MFAM, A NEW SEPARATE ASSET MANAGEMENT COMPANY, TO SUPPORT ITS PHILANTHROPIC MISSION

Retrieved on: 
torsdag, maj 2, 2024

TORONTO, May 2, 2024 /PRNewswire/ -- The Mastercard Foundation today introduced the Mastercard Foundation Asset Management (MFAM) Corporation, a new, separate asset management company with a mandate to build and manage a diversified portfolio to support the mission of the Mastercard Foundation and the work of its partners over the long term. The Mastercard Foundation is a registered Canadian charity and one of the largest private foundations in the world. It works with visionary organizations to advance education and financial inclusion to enable young people in Africa and Indigenous youth in Canada to access dignified and fulfilling work.

Key Points: 
  • TORONTO, May 2, 2024 /PRNewswire/ -- The Mastercard Foundation today introduced the Mastercard Foundation Asset Management (MFAM) Corporation , a new, separate asset management company with a mandate to build and manage a diversified portfolio to support the mission of the Mastercard Foundation and the work of its partners over the long term.
  • The Mastercard Foundation was established in 2006 through the generosity of Mastercard Incorporated (NYSE: MA), which gifted the Mastercard Foundation common shares as part of its initial public offering.
  • The Mastercard Foundation now requires a dedicated asset management team to manage and diversify the Mastercard Foundation's growing investment portfolio.
  • MFAM was established by the Mastercard Foundation as a separate entity with a separate Board of Directors and management team.

Qualtrics X4 Kicks Off in Salt Lake City

Retrieved on: 
onsdag, maj 1, 2024

SALT LAKE  CITY, May 1, 2024 /PRNewswire/ -- QUALTRICS X4 -- Qualtrics, the leader and creator of the experience management category, today announced the official kickoff of X4®: The Experience Management Summit. The world's largest gathering of experience management (XM) professionals is taking place May 1-3 at the Salt Palace Convention Center in Salt Lake City. The X4 mainstage program will begin with a keynote from Qualtrics CEO Zig Serafin.

Key Points: 
  • The world's largest gathering of experience management (XM) professionals is taking place May 1-3 at the Salt Palace Convention Center in Salt Lake City.
  • The X4 mainstage program will begin with a keynote from Qualtrics CEO Zig Serafin.
  • "We have a fantastic line-up of visionary leaders who will inspire and prepare everyone at X4 to improve the experiences at their own organizations," said Qualtrics CEO Zig Serafin.
  • "X4 is a can't-miss event for executives, thought leaders and experience management professionals who are unlocking growth by creating emotional connections at scale with their customers and employees."